Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 15 of 25
Decision Aid for Therapeutic Options In Sickle Cell Disease
NCT02326597
BMT Autologous MSCs for GvHD
NCT02359929
Characterization and Modulation of Mucosal Immunity for HIV Prevention in Women
NCT02333045
Reliability of Sensor Spacing for NIRS in Traumatic Tibia Fractures
NCT02301832
Legume Diet Satiety Pilot Study
NCT02269631
Development of a Manual-based, Interdisciplinary Intervention for Youth With ASD and Obesity
NCT02328638
Ganetespib Window of Opportunity Study in Head and Neck Cancers
NCT02334319
Phase II Study of Everolimus Beyond Progression
NCT02269670
Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program
NCT02300584
Redox Imbalance and the Development of Cystic Fibrosis Diabetes
NCT02202876
A Mobile Personal Health Record for Behavioral Health Homes
NCT01890226
Community Pediatric Acceptability Study (CPAS)
NCT02610699
Pegylated Interferon ALFA-2b in Children With Juvenile Pilocytic Astrocytomas and Optic Pathway Gliomas
NCT02343224
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer
NCT02273752
Impact of a Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL) by Maintaining a Database
NCT02309333
Post-operative Pain Control After Pediatric Adenotonsillectomy
NCT02296840
Researching Alveolar Macrophage Improvements With Supplements in HIV
NCT02264860
Reducing Perinatal Anal Incontinence Through Early Pelvic Floor Muscle Training: a Prospective Pilot Study
NCT02270008
NOninVasive Intracranial prEssure From Transcranial doppLer Ultrasound Development of a Comprehensive Database of Multimodality Monitoring Signals for Brain-Injured Patients
NCT04548596
BioEnergetics and Metabolomics in Cystic Fibrosis
NCT02225899
The ISLAND Study: InSuLa Assessed Needs for Depression
NCT02137369
Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
NCT02147067
iChoose Decision Kidney Aid for End-Stage Renal Disease Patients
NCT02235571
CAndesartan vs LIsinopril Effects on the BRain
NCT01984164
Liposomal Bupivacaine for Pain Control Following Anterior Cruciate Ligament Reconstruction
NCT02189317
Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors
NCT02257476
Online CBT-I for High Blood Pressure
NCT02299193
Video-Based Treatment Options for Basal Cell Carcinoma
NCT02158650
Improving Consent and Survey Procedures for Young MSM in Web-based HIV Prevention
NCT02139566
Planning for SUCCESS
NCT02185742
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720
Living Well Project for Persons With AIDS
NCT01848483
Improving Patient Education for Lymphoma and Leukemia Inpatients
NCT02642510
Stimulus-Stimulus Pairing Study
NCT02464527
CBCT for Parents of Children With Autism
NCT02574559
Music for Health Project
NCT01786148
PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)
NCT02074436
Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
NCT02132195
Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels
NCT02098876
Meditation for Emotional Numbing in Post-Traumatic Stress Disorder
NCT02163941
Propranolol and Botulinum Toxin for Essential Vocal Tremor
NCT02111369
ADA Linagliptin in Long Term Care
NCT02061969
Systems Biology of PNEUMOVAX®23 and PREVNAR 13®
NCT01307449
Cast vs. Splints for Minimally Displaced Distal Radius Fractures in the Elderly
NCT02066857
Comparison of Gabapentin and Pregabalin for Radicular Pain
NCT02064790
Mucosal Versus Fecal Microbiota in FMT
NCT02133651
RF Lesion Monitoring With 8mm IntellaTip MiFi XP
NCT02089672
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
NCT02114697
rTMS in Treatment Resistant Depression
NCT02080507
Liraglutide Hospital Discharge Trial
NCT01919489
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Emory University pipeline card: 1,208 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.